Should you buy, sell or hold Wipro, Bajaj Auto, L&T, Dr Reddy's, Aditya Birla Fashion shares?

Brokerages are bullish on Dr Reddy's Laboratories, Bajaj Auto, L&T and Aditya Birla Fashion, and skeptical on Wipro. Here's what top brokerages recommend on some of the key stocks in focus today.

Here is a look at what top brokerages recommend on Bajaj Auto, L&T and Wipro. Source: Pixabay

Brokerages are upbeat on Dr Reddy’s Laboratories, a day after the pharma major announced an acquisition. Here's what they recommend on stocks such as Bajaj Auto, Wipro and Larsen & Toubro (L&T).

Check out the ratings and target prices assigned to these stocks on February 28:

Dr Reddy’s Laboratories shares

Dr Reddy's Laboratories has announced an agreement to acquire Australia-based Mayne Pharma’s US generic prescription product portfolio.

Morgan Stanley has maintained an ‘overweight’ rating on Dr Reddy’s with a target price of Rs 5,099 per share,

TRENDING NOW

Brokerage	Rating	Target price
Morgan Stanley	Overweight	Rs 5,099
Jefferies	Buy	Rs 4,965
Macquarie	Outperform	Rs 4,915

According to Morgan Stanley, the Mayne US generic acquisition of Dr Reddy’s is value accretive, and should bolster the Indian company’s US portfolio. The acquisition remains an integral part of the company’s growth strategy, the brokerage adds.

Bajaj Auto shares

Morgan Stanley has retained an ‘overweight’ rating on Bajaj Auto with a target price of Rs 4,449 per share.

Aditya Birla Fashion and Retail shares

Citi has a ‘buy’ rating on Aditya Birla Fashion and Retail and reduced its target to Rs 347 apiece from Rs 405.

Wipro shares

Morgan Stanley has continued with an ‘underweight’ rating on Wipro with a target price of Rs 375 per share. According to the brokerage, the company has seen considerable organic and inorganic growth in the last two years and a half.